The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Brigitte Kaiser

Friedrich Schiller University Jena

Center for Vascular Biology and Medicine Erfurt

Germany

[email]@*.ef.uni-jena.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Friedrich Schiller University Jena, Center for Vascular Biology and Medicine Erfurt, Germany. 1998 - 2003
  • Friedrich Schiller University Jena, Erfurt, Germany. 1997

References

  1. DX-9065a, a direct inhibitor of factor Xa. Kaiser, B. Cardiovasc. Drug. Rev (2003) [Pubmed]
  2. DX-9065a Daiichi. Kaiser, B. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  3. Tissue factor pathway inhibitor: an update of potential implications in the treatment of cardiovascular disorders. Kaiser, B., Hoppensteadt, D.A., Fareed, J. Expert. Opin. Investig. Drugs (2001) [Pubmed]
  4. A synthetic inhibitor of factor Xa, DX-9065a, reduces proliferation of vascular smooth muscle cells in vivo in rats. Kaiser, B., Paintz, M., Scholz, O., Kunitada, S., Fareed, J. Thromb. Res. (2000) [Pubmed]
  5. Inactivation of factor Xa by the synthetic inhibitor DX-9065a causes strong anticoagulant and antiplatelet actions in human blood. Kaiser, B., Jeske, W., Walenga, J.M., Fareed, J. Blood Coagul. Fibrinolysis (1999) [Pubmed]
  6. Synthetic and recombinant antithrombin drugs. Kaiser, B., Callas, D., Walenga, J.M., Fareed, J. Expert. Opin. Investig. Drugs (1998) [Pubmed]
  7. Recombinant TFPI and variants: potential implications in the treatment of cardiovascular disorders. Kaiser, B., Hoppensteadt, D.H., Fareed, J. Expert. Opin. Investig. Drugs (1998) [Pubmed]
  8. A supersulfated low-molecular-weight heparin (IK-SSH) increases plasma levels of free and total tissue factor pathway inhibitor after intravenous and subcutaneous administration in humans. Kaiser, B., Glusa, E., Hoppensteadt, D.A., Breddin, H.K., Amiral, J., Fareed, J. Blood Coagul. Fibrinolysis (1998) [Pubmed]
  9. In vitro studies on the effect of activated protein C on platelet activation and thrombin generation. Kaiser, B., Jeske, W., Hoppensteadt, D.H., Walenga, J.M., Drohan, W., Fareed, J. Thromb. Res. (1997) [Pubmed]
 
WikiGenes - Universities